Although both FLT3L and CD1c+DCs were significantly decreased, and FLT3 was significantly increased in SLE patients, the changes of FLT3 and its ligand were smaller than that of CD1c+DCs in SLE patients. This evidence concerns the gene FLT3 and systemic lupus erythematosus.